<a href="https://www.fiercebiotech.com/biotech/chutes-ladders-astellas-appoints-new-top-strategist-sanofi-japan" hreflang="en">Chutes & Ladders—Astellas appoints new top strategist from Sanofi Japan</a>
fiercebiotech.com·Apr 30, 2026
Astellas Pharma has appointed Takahiko Iwaya as its new chief strategy officer, replacing Adam Pearson, while Immunic has hired Michael Panzara as chief medical officer to advance its multiple sclerosis candidate. Additionally, Nuevocor has brought on cardiologist Monica Shah as chief medical officer to lead its gene therapy initiatives.
There's no actionable insight specifically related to healthtech, digital health, AI drug discovery, or related areas you track in this content. The information primarily focuses on leadership changes within biotech companies, which may not directly impact your specific areas of interest unless you're tracking particular companies like Astellas, Immunic, or Nuevocor for strategic shifts.